The Valley Desk

NCT00101660 · Interventional trial

Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib

Overall registry status Completed

Phase 2

Conditions Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov